Abstract
Aim: To study the effects of an extract solution from radix curcumae on the expressions of VEGF, COX-2 and PCNA in gastric mucosa of rats during carcinogenesis induced MNNG. Methods: Eighty male Wistar rats were randomly divided into 5 groups: group A, water and normal saline; group B, MNNG and normal saline; group C, MNNG and celecoxib; group D, MNNG and low-dose (1g/ml) radix curcumae steam distillation extract solution; group E, MNNG and high-dose (2g/ml) radix curcumae wet distillation extract solution. In the end of the 40th week, all rats alive were sacrificed and the expressions of VEGF, COX-2 and PCNA in gastric mucosa were determined by immunohistochemistry. Results: The expression levels of VEGF and COX-2 and the optical density levels of PCNA in group C, D and E were remarkably lower than that of group B (P < 0.05), while the optical density levels of PCNA in group E were higher than that of group C and D (P < 0.05). Conclusions: The distilled extract of curcumae can down-regulate the expressions of VEGF, COX-2 and PCNA in the gastric mucosa of rats during carcinogenesis induced MNNG and can reduce the incidence of gastric caner, suggesting it maybe as a potential chemopreventive agent for gastric cancer.
Keywords: Cyclooxygenase-2 (COX-2), gastric cancer, N-methyl-N-nitro-N-nitrosoguanidine (MNNG), proliferating cell nuclear antigen (PCNA), radix curcumae, vascular endothelial growth factor (VEGF)
Current Pharmaceutical Biotechnology
Title: The Effects of Radix Curcumae Extract on Expressions of VEGF, COX-2 and PCNA in Gastric Mucosa of Rats Fed with MNNG
Volume: 11 Issue: 3
Author(s): Bin Lu, Linfeng Yu, Lei Xu, Hanqing Chen, Lu Zhang and Yanjun Zeng
Affiliation:
Keywords: Cyclooxygenase-2 (COX-2), gastric cancer, N-methyl-N-nitro-N-nitrosoguanidine (MNNG), proliferating cell nuclear antigen (PCNA), radix curcumae, vascular endothelial growth factor (VEGF)
Abstract: Aim: To study the effects of an extract solution from radix curcumae on the expressions of VEGF, COX-2 and PCNA in gastric mucosa of rats during carcinogenesis induced MNNG. Methods: Eighty male Wistar rats were randomly divided into 5 groups: group A, water and normal saline; group B, MNNG and normal saline; group C, MNNG and celecoxib; group D, MNNG and low-dose (1g/ml) radix curcumae steam distillation extract solution; group E, MNNG and high-dose (2g/ml) radix curcumae wet distillation extract solution. In the end of the 40th week, all rats alive were sacrificed and the expressions of VEGF, COX-2 and PCNA in gastric mucosa were determined by immunohistochemistry. Results: The expression levels of VEGF and COX-2 and the optical density levels of PCNA in group C, D and E were remarkably lower than that of group B (P < 0.05), while the optical density levels of PCNA in group E were higher than that of group C and D (P < 0.05). Conclusions: The distilled extract of curcumae can down-regulate the expressions of VEGF, COX-2 and PCNA in the gastric mucosa of rats during carcinogenesis induced MNNG and can reduce the incidence of gastric caner, suggesting it maybe as a potential chemopreventive agent for gastric cancer.
Export Options
About this article
Cite this article as:
Lu Bin, Yu Linfeng, Xu Lei, Chen Hanqing, Zhang Lu and Zeng Yanjun, The Effects of Radix Curcumae Extract on Expressions of VEGF, COX-2 and PCNA in Gastric Mucosa of Rats Fed with MNNG, Current Pharmaceutical Biotechnology 2010; 11 (3) . https://dx.doi.org/10.2174/138920110791111915
DOI https://dx.doi.org/10.2174/138920110791111915 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
Call for Papers in Thematic Issues
Artificial Intelligence in Bioinformatics
Bioinformatics is an interdisciplinary field that analyzes and explores biological data. This field combines biology and information system. Artificial Intelligence (AI) has attracted great attention as it tries to replicate human intelligence. It has become common technology for analyzing and solving complex data and problems and encompasses sub-fields of machine ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Recent Progress in the Development of Selective TRPV1 Antagonists for Pain
Current Topics in Medicinal Chemistry The Small Bowel: An Imaging Guide
Current Medical Imaging Isothiocyanates as Cancer Chemopreventive Agents: Their Biological Activities and Metabolism in Rodents and Humans
Current Drug Metabolism The c-Met Inhibitors: A New Class of Drugs in the Battle Against Advanced Nonsmall- Cell Lung Cancer
Current Pharmaceutical Design Inhibition of Cyclin-Dependent Kinases - A Review of the Recent Patent Literature
Recent Patents on Anti-Cancer Drug Discovery Modulation of GSTP1-1 Oligomerization by Electrophilic Inflammatory Mediators and Reactive Drugs
Inflammation & Allergy - Drug Targets (Discontinued) Role of Nanoparticles in Drug Delivery and Regenerative Therapy for Bone Diseases
Current Drug Delivery Lycopene Modulation of Molecular Targets Affected by Smoking Exposure
Current Cancer Drug Targets MiR-143HG Gene Polymorphisms as Risk Factors for Gastric Cancer in Chinese Han Population
Current Molecular Medicine Why Antidiabetic Vanadium Complexes are Not in the Pipeline of “Big Pharma” Drug Research? A Critical Review
Current Medicinal Chemistry The ErbB Receptors and their Ligands in Cancer: An Overview
Current Drug Targets Serum Biochemical Markers of Brain Injury
Mini-Reviews in Medicinal Chemistry An Overview on the Role of miR-451 in Lung Cancer: Diagnosis, Therapy, and Prognosis
MicroRNA Ursolic Acid in Cancer Treatment and Metastatic Chemoprevention: From Synthesized Derivatives to Nanoformulations in Preclinical Studies
Current Cancer Drug Targets Meet Our Associate Editor:
Current Molecular Medicine Bioinformatics Analysis Identifies CPZ as a Tumor Immunology Biomarker for Gastric Cancer
Current Bioinformatics The Gene Expression Profiles of Medulloblastoma Cell Lines Resistant to Preactivated Cyclophosphamide
Current Cancer Drug Targets Targeted Therapies in the Treatment of Advanced Renal Cell Carcinoma
Recent Patents on Anti-Cancer Drug Discovery Profiling of Autophagy-Associated microRNAs in the Osteosarcoma Cell Line of U2OS
Anti-Cancer Agents in Medicinal Chemistry Ghrelin: A Molecular Target for Weight Regulation, Glucose and Lipid Metabolism
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery